Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
40762119	s-rnp70ab	— (—)	3083	3494	100.00%	Distribution not available
40762119	s-rnp70	— (—)	243	288	100.00%	Distribution not available
40762119	s-rnp70ab	u/ml (u/ml)	36	50	0.00%
40762119	s-rnp70	u/ml (u/ml)	5	6	0.00%		Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Finngen Rheumatological endpoints

1040

1409

4.25

319.47

1.2

1.1

70.67

24.44

u/ml

—

Autoimmune diseases related-to ILD

975

2155

3.92

313.24

1.3

1.1

74.58

60.93

u/ml

0.25

L04AX Other immunosuppressants

769

1740

4.51

309.60

1.2

1.1

80.32

49.94

u/ml

0.96

Autoimmune diseases excluding thyroid diseases

1184

1498

4.37

307.65

1.2

1.1

71.53

22.83

u/ml

—

Reimbursement for rheumatic diseases

824

1740

4.82

307.65

1.2

1.1

74.28

49.58

u/ml

—

Systemic connective tissue disorders

882

884

10.46

307.65

1.3

1.1

78.74

12.24

u/ml

—

ILD medications

1205

1681

3.93

307.65

1.2

1.1

79.40

31.56

u/ml

2.31

Other systemic involvement of connective tissue

660

709

9.74

307.65

1.3

1.1

81.33

12.24

u/ml

—

ILD medications: immunosuppressive drugs

935

1521

5.83

307.65

1.2

1.1

80.92

29.22

u/ml

—

Autoimmune diseases excluding thyroid diseases, strict definition

1138

1455

4.34

307.65

1.2

1.1

71.53

22.83

u/ml

—

Second line medication for Crohn's disease

778

1804

4.40

303.50

1.2

1.1

80.32

47.45

u/ml

1.17

ILD medications: prednisolone, methylprednisolone, prednisone

1073

1650

3.68

272.65

1.2

1.1

67.86

31.56

u/ml

1.54

Polyarthropathies

744

1137

4.33

247.45

1.2

1.1

48.50

82.25

u/ml

0.97

Other specific joint derangements/joint disorders

787

1302

3.95

232.73

1.1

18.38

85.22

u/ml

—

Inflammatory bowel disease treatment related agents

1103

1999

3.12

220.17

1.2

1.1

76.26

49.56

u/ml

0.95

Pain in joint

667

1010

4.27

215.91

1.1

21.33

75.12

u/ml

—

Oral corticosteroids

1018

1937

3.15

210.89

1.2

1.1

71.47

49.27

u/ml

0.70

Autoimmune diseases

982

1512

3.33

209.87

1.2

1.1

56.27

22.83

u/ml

—

Used for control exclusion in common control thyroid runs

920

1384

3.39

200.94

1.2

1.1

68.87

22.83

u/ml

—

First line medication for Crohn's disease

1015

1794

3.09

197.20

1.2

1.1

67.68

58.55

u/ml

0.20

Other specified/unspecified arthritis

324

603

5.48

164.73

1.2

1.1

70.50

79.90

u/ml

—

Rheumatoid arthritis

365

657

5.07

164.04

1.2

1.1

60.50

65.70

u/ml

—

Examination and observation for other reasons

583

967

3.53

142.06

1.1

51.29

82.20

u/ml

—

Rheumatoid arthritis, including avohilmo

412

1172

3.57

121.07

1.2

1.1

75.33

53.84

u/ml

—

Arthropathies

729

1332

2.79

117.71

1.2

1.1

37.67

84.61

u/ml

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

825

2319

2.47

115.63

1.2

1.1

70.90

58.47

u/ml

—

Other soft tissue disorders, not elsewhere classified

773

1751

2.61

115.21

1.2

1.1

54.83

77.97

u/ml

—

Pain in limb

680

1711

2.68

111.10

1.2

1.1

71.17

70.83

u/ml

—

Other joint disorders

683

1325

2.74

107.99

1.1

14.17

84.61

u/ml

—

Dermatitis and eczema

866

2438

2.22

92.71

1.2

1.1

82.27

54.58

u/ml

0.56

Azathioprine

186

357

5.32

91.71

1.3

1.1

45.33

50.15

u/ml

—

General symptoms and signs

813

1779

2.30

89.66

1.2

1.1

56.69

61.70

u/ml

—

Fever of other and unknown origin

457

1450

2.83

89.19

1.2

1.1

97.75

48.27

u/ml

—

L04AA Selective immunosuppressants

268

722

3.78

85.74

1.3

1.1

52.86

36.03

u/ml

—

Headache

532

1668

2.57

83.86

1.2

1.1

38.02

56.00

u/ml

—

Other disorders of lacrimal gland

344

1111

3.14

82.58

1.2

1.1

78.00

28.32

u/ml

—

Diseases of the skin and subcutaneous tissue

725

1566

2.34

82.57

1.2

1.1

76.33

53.36

u/ml

—

Disorders of lacrimal system

392

1383

2.86

79.93

1.2

1.1

78.00

28.71

u/ml

—

Tramadol

612

1569

2.41

79.34

1.2

1.1

57.53

64.78

u/ml

—

Other and unspecified dermatitis

432

1658

2.63

75.17

1.2

1.1

83.20

43.57

u/ml

—

Dermatitis

482

1983

2.44

71.80

1.2

1.1

83.20

43.49

u/ml

—

Asthma, excluding more controls

563

1212

2.44

71.19

1.2

1.1

48.02

61.06

u/ml

—

Asthma (mode)

566

1277

2.39

69.13

1.1

48.02

61.06

u/ml

—

Asthma

571

1269

2.37

68.40

1.2

1.1

48.02

61.06

u/ml

—

Seropositive rheumatoid arthritis, wide

265

826

3.26

67.69

1.2

1.1

71.20

34.87

u/ml

—

Other/unspecified seropositive rheumatoid arthritis

260

815

3.24

65.81

1.2

1.1

71.20

34.87

u/ml

—

Asthma, unspecified (mode), excluding more controls

395

1123

2.65

65.55

1.2

1.1

41.40

59.00

u/ml

—

Disorders of eyelid, lacrimal system and orbit

633

2266

2.13

65.16

1.2

1.1

70.33

51.66

u/ml

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

258

812

3.22

64.89

1.2

1.1

71.20

34.87

u/ml

—

Asthma, unspecified (mode)

398

1176

2.57

62.11

1.2

1.1

41.40

59.00

u/ml

—

Asthma (only as main-diagnosis), excluding more controls

491

1212

2.33

58.11

1.1

49.17

61.06

u/ml

—

Bacterial infection, other or unspecified

414

1466

2.41

57.89

1.2

1.1

88.80

47.60

u/ml

—

Abnormalities of breathing

636

1785

2.08

57.71

1.2

1.1

58.50

64.49

u/ml

—

Abnormal findings on examination of blood, without diagnosis

335

1178

2.63

57.61

1.2

1.1

55.40

44.52

u/ml

—

Pain in throat and chest

603

1724

2.11

57.32

1.2

1.1

71.33

62.79

u/ml

—

Soft tissue disorders

694

1767

2.03

57.31

1.2

1.1

40.60

77.97

u/ml

—

Asthma (only as main-diagnosis)

499

1269

2.29

56.98

1.1

49.17

61.06

u/ml

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

463

1851

2.25

56.46

1.2

1.1

52.38

46.36

u/ml

—

Cardiovascular diseases

475

1097

2.34

55.85

1.1

59.71

83.50

u/ml

0.52

Abnormal findings on diagnostic imaging of lung

342

1294

2.55

55.84

1.1

57.67

35.02

u/ml

—

Codeine

648

1747

2.03

53.88

1.2

1.1

24.60

72.28

u/ml

—

Diseases of oesophagus, stomach and duodenum

726

2289

1.91

52.12

1.2

1.1

94.00

52.37

u/ml

—

Disorders of conjunctiva

613

2519

1.96

51.20

1.1

71.75

59.69

u/ml

—

GASTRO-related operations

566

1368

2.09

49.75

1.1

45.14

73.86

u/ml

—

Any gastric operation

566

1368

2.09

49.75

1.1

45.14

73.86

u/ml

—

Dorsalgia

670

1861

1.94

49.16

1.2

1.1

78.25

75.64

u/ml

—

Codeine or tramadol medication

760

2254

1.85

49.11

1.2

1.1

24.60

66.10

u/ml

—

Hypothyroidism, strict autoimmune

424

1240

2.26

48.82

1.2

1.1

60.71

22.83

u/ml

—

Conjunctivitis

562

2396

1.97

47.75

1.1

78.43

61.59

u/ml

—

Asthma (diagnoses ohter than nonallergic)

606

2654

1.90

46.53

1.1

35.40

65.52

u/ml

—

Opioids

645

1777

1.89

44.02

1.1

29.87

72.28

u/ml

—

Other bacterial diseases

673

2335

1.84

43.91

1.2

1.1

87.63

51.45

u/ml

—

Nerve, nerve root and plexus disorders

698

2360

1.82

43.84

1.2

1.1

76.83

56.05

u/ml

—

Symptoms and signs involving the circulatory and respiratory systems

666

1791

1.87

43.45

1.2

1.1

49.33

64.49

u/ml

—

Other bacterial diseases

620

2244

1.87

43.03

1.2

1.1

89.83

56.62

u/ml

—

Other dorsopathies, not elsewhere classified

661

1870

1.86

42.70

1.1

37.84

75.64

u/ml

—

Antihypertensive medication - note that there are other indications

459

1181

2.07

40.41

1.1

67.45

62.57

u/ml

0.08

596

1946

1.86

40.25

1.2

1.1

60.83

66.33

u/ml

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

596

1946

1.86

40.25

1.2

1.1

60.83

66.33

u/ml

—

Gastro-oesophageal reflux disease

452

1968

1.99

40.05

1.2

1.1

71.67

55.59

u/ml

—

Dyspnoea

593

2405

1.83

39.57

1.2

1.1

82.63

52.88

u/ml

—

All anxiety disorders

459

1845

1.98

39.13

1.1

90.60

68.89

u/ml

—

Persons encountering health services for specific procedures and health care

719

2488

1.74

38.80

1.1

1.2

76.44

56.81

u/ml

—

Dorsopathies

666

1888

1.80

38.75

1.1

9.03

75.64

u/ml

—

Cardiovascular diseases (excluding rheumatic etc)

463

1333

2.01

38.40

1.1

55.38

78.00

u/ml

0.47

Other intervertebral disc disorders

525

1663

1.91

38.21

1.2

1.1

24.53

79.39

u/ml

—

Neurotic, stress-related and somatoform disorders

614

2403

1.80

38.12

1.2

1.1

65.56

66.07

u/ml

—

Anxiety disorders

618

2414

1.79

38.07

1.2

1.1

65.56

66.07

u/ml

—

Urticaria and erythema

293

1292

2.29

37.99

1.2

1.1

97.71

50.38

u/ml

—

Anxiety (asthma-related co-morbidities)

447

1759

1.98

37.96

1.1

1.2

90.60

65.92

u/ml

—

Depression

641

2499

1.75

35.97

1.1

73.14

63.98

u/ml

—

Provisional assignment of new diseases of uncertain etiology

359

1755

2.05

35.63

1.2

1.1

108.00

47.21

u/ml

—

Codes for special purposes

359

1755

2.05

35.63

1.2

1.1

108.00

47.21

u/ml

—

Diseases of salivary glands

247

1041

2.39

35.62

1.2

1.1

93.00

32.52

u/ml

—

Anxiety disorders, excluding more controls

563

2031

1.81

35.50

1.2

77.43

67.08

u/ml

—

Asthma, including avohilmo

753

2541

1.67

34.68

1.1

48.02

68.97

u/ml

—

Mood [affective] disorders

668

2543

1.71

34.52

1.1

73.14

62.07

u/ml

—

Influenza and pneumonia

684

2569

1.70

34.48

1.2

1.1

65.88

61.01

u/ml

—

Neurological diseases

559

1538

1.83

34.48

1.1

57.60

66.67

u/ml

—

Mood disorders

668

2544

1.71

34.26

1.1

73.14

62.07

u/ml

—

Shoulder lesions

443

1402

1.92

33.08

1.1

44.67

67.02

u/ml

—

Pneumonias (Asthma/COPD co-morbidities)

644

2559

1.70

32.64

1.2

1.1

74.29

57.44

u/ml

—

Diseases of the eye and adnexa

521

1424

1.84

32.52

1.1

62.17

80.88

u/ml

—

Tumor necrosis factor alpha inhibitors

148

508

2.95

32.36

1.2

1.1

—

50.15

—

All pneumoniae

645

2567

1.69

31.94

1.2

1.1

74.29

57.44

u/ml

—

Aplastic and other anaemias

273

1175

2.18

31.28

1.2

1.1

55.20

34.62

u/ml

—

Viral infections characterized by skin and mucous membrane lesions

553

2764

1.72

30.69

1.2

1.1

102.89

53.54

u/ml

—

Chronic lower respiratory diseases

754

2492

1.62

30.34

1.1

54.10

66.33

u/ml

0.29

Metabolic disorders

579

2065

1.72

30.17

1.1

54.50

64.15

u/ml

—

Mycoses

543

2769

1.71

29.93

1.2

1.1

25.50

70.98

u/ml

—

Visual disturbances

323

1625

2.00

29.88

1.2

1.1

66.86

50.95

u/ml

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

618

2536

1.67

29.61

1.2

1.1

74.29

59.22

u/ml

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

688

2295

1.63

29.11

1.1

93.29

52.77

u/ml

—

Hypertensive diseases (excluding secondary)

346

1005

2.01

29.07

1.1

39.31

73.89

u/ml

—

Pneumonia, organism unspecified

562

2329

1.70

28.94

1.2

1.1

90.60

57.37

u/ml

—

Psoriasis vulgaris

145

525

2.79

28.75

1.1

—

29.87

—

Asthma, hospital admissions , main diagnosis only

523

2715

1.71

28.55

1.1

49.17

61.56

u/ml

—

Visual disturbances and blindness

337

1760

1.93

27.95

1.2

1.1

66.86

48.51

u/ml

—

Other heart diseases

315

1021

2.02

27.80

1.2

1.1

61.00

81.10

u/ml

—

Heart failure, not strict

439

1663

1.80

27.56

1.2

1.1

71.38

39.16

u/ml

—

Condition for Implicit Sepsis (Organ dysfunction codes)

553

2282

1.68

27.16

1.1

30.80

59.04

u/ml

—

COPD/asthma related infections

636

1946

1.64

26.92

1.2

1.1

49.90

66.33

u/ml

—

COPD/asthma/ILD related infections

636

1946

1.64

26.92

1.2

1.1

49.90

66.33

u/ml

—

Gastrointestinal diseases

371

969

1.93

26.69

1.1

60.80

59.94

u/ml

—

Diseases of the respiratory system

392

1045

1.89

26.58

1.2

1.1

41.64

56.85

u/ml

—

Episodal and paroxysmal disorders

672

2144

1.60

25.80

1.1

60.27

67.79

u/ml

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

301

954

2.00

25.62

1.2

1.1

47.67

62.57

u/ml

—

Disorders of sclera, cornea, iris and ciliary body

343

1856

1.86

25.58

1.1

106.83

41.41

u/ml

—

Viral hepatitis, IBD co-morbidity

6.99

25.03

1.1

—

Cystitis

543

1954

1.66

24.88

1.1

40.89

65.63

u/ml

—

Dermatopolymyositis

9.06

24.75

1.6

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

568

2240

1.63

24.69

1.2

1.1

50.56

49.69

u/ml

—

Other diseases of intestines

641

2300

1.59

24.62

1.2

1.1

79.00

63.86

u/ml

—

Hypertension, essential

474

1566

1.72

24.57

1.2

1.1

25.17

71.29

u/ml

—

Other diseases of upper respiratory tract

644

2123

1.59

24.02

1.2

1.1

61.31

56.81

u/ml

—

Caries of enamel

559

2508

1.61

23.93

1.2

1.1

47.67

64.31

u/ml

—

Care involving use of rehabilitation procedures

396

2092

1.75

23.88

1.1

1.2

78.83

46.10

u/ml

—

Urticaria

221

1055

2.11

23.76

1.1

104.80

50.38

u/ml

—

Respiratory disorders in diseases classified elsewhere

8.63

23.75

1.9

1.1

—

Other gastritis (incl. Duodenitis)

146

586

2.51

23.62

1.1

—

27.24

—

Endocrine, nutritional and metabolic diseases

497

1500

1.68

23.29

1.1

32.37

69.44

u/ml

—

Other special examinations and investigations of persons without complaint or reported diagnosis

352

970

1.84

22.43

1.2

1.1

78.84

82.20

u/ml

—

Any operation in hilmo

14.53

22.25

1.2

1.0

—

Internal derangement of knee

190

879

2.16

21.85

1.1

—

83.02

—

669

2263

1.53

21.50

1.2

1.1

47.40

63.62

u/ml

—

Parasetamol

443

1332

1.69

21.16

1.1

48.60

69.32

u/ml

—

Other heart diseases, wide

558

2186

1.57

20.52

1.2

1.1

61.00

63.62

u/ml

—

Complications of surgical and medical care, not elsewhere classified

575

2560

1.54

20.26

1.1

65.90

56.81

u/ml

—

107

400

2.70

20.12

1.1

—

50.15

—

Abnormalities of heart beat

207

1009

2.02

19.93

1.2

1.1

101.40

59.37

u/ml

—

Spinal stenosis

264

1066

1.89

19.93

1.2

1.1

—

51.12

—

Gingivitis and periodontal diseases

574

1910

1.56

19.79

1.1

56.37

66.23

u/ml

—

Other enthesopathies

179

847

2.13

19.78

1.1

—

49.24

—

Other disorders of veins

255

1370

1.86

19.27

1.1

45.83

37.69

u/ml

—

Disorders of the thyroid gland

546

2318

1.54

18.86

1.2

1.1

58.38

56.28

u/ml

—

Hypertension

459

1618

1.61

18.55

1.2

1.1

41.15

69.40

u/ml

—

Hypertensive diseases

459

1619

1.61

18.52

1.2

1.1

41.15

69.40

u/ml

—

Hypothyroidism, other/unspecified

518

2208

1.55

18.44

1.2

1.1

65.13

56.33

u/ml

—

Triptan medication for migraine, single purchase ok

485

2105

1.57

18.27

1.1

1.2

64.37

62.62

u/ml

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

485

2105

1.57

18.27

1.1

1.2

64.37

62.62

u/ml

—

Other diseases of urinary system

578

2147

1.52

18.24

1.1

32.27

65.43

u/ml

—

Asthma/COPD (KELA code 203)

549

2489

1.52

17.97

1.1

52.17

66.33

u/ml

—

Acute upper respiratory infections

596

2468

1.49

17.69

1.1

69.17

59.37

u/ml

—

Bronchitis

618

2640

1.48

17.62

1.2

1.1

70.63

60.07

u/ml

—

Zoster [herpes zoster]

279

1576

1.75

17.27

1.2

1.1

88.14

42.89

u/ml

—

Purpura and other haemorrhagic conditions

372

2.61

16.89

1.3

1.1

—

33.64

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

533

2326

1.51

16.87

1.2

1.1

65.13

59.30

u/ml

—

Acute upper respiratory infections of multiple and unspecified sites

436

2072

1.56

16.70

1.1

94.60

65.37

u/ml

—

Subjective visual disturbances

166

820

2.04

16.48

1.1

88.80

41.60

u/ml

—

Complications of procedures, not elsewhere classified

458

2475

1.54

16.47

1.1

74.25

56.05

u/ml

—

Other septicaemia

192

957

1.94

16.46

1.2

1.1

—

28.69

—

Complications of medical and surgical care

414

2442

1.56

16.38

1.2

1.1

49.40

56.41

u/ml

—

Abdominal and pelvic pain

548

1833

1.51

16.36

1.2

1.1

54.64

65.04

u/ml

—

Intestinal infectious diseases

648

2567

1.45

16.23

1.1

90.50

56.10

u/ml

—

Diarrhoea and gastroenteritis of presumed infectious origin

576

2605

1.46

15.70

1.1

82.60

56.10

u/ml

—

Other and unspecified urticaria

138

652

2.13

15.47

1.2

1.1

104.80

36.03

u/ml

—

Recurrent aphthous stomatitis , including avohilmo

104

445

2.36

14.86

1.1

—

29.87

—

Any mental disorder

612

2130

1.44

14.79

1.1

58.67

64.72

u/ml

—

Stomatitis and related lesions

131

619

2.13

14.71

1.1

—

50.15

—

Nonorganic sleeping disorders, excluding more controls

125

600

2.10

13.51

1.1

—

61.90

—

Nephrotic syndrome

4.64

12.87

1.2

1.1

—

Temporomandibular joint disorders, including avohilmo

283

1748

1.60

12.71

1.3

1.1

77.38

62.49

u/ml

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

473

2209

1.45

12.57

1.1

60.71

60.62

u/ml

—

Fibroblastic disorders

114

544

2.11

12.54

1.2

1.1

—

32.64

—

Pain and other conditions associated with female genital organs and menstrual cycle

142

676

1.94

12.29

1.1

—

53.37

—

Intestinal infectious diseases

515

2776

1.41

12.06

1.2

1.1

121.67

54.55

u/ml

—

Hyperkinetic disorders, excluding more controls

309

2.43

11.97

1.1

1.2

—

74.82

—

Periodontitis

507

2397

1.42

11.96

1.2

1.1

60.50

63.43

u/ml

—

Spondyloarthritis

439

2.20

11.79

1.2

1.1

—

36.03

—

Drug-induced systemic lupus erythematosus

10.88

11.77

1.6

1.1

—

Chronic periodontitis, including avohilmo

503

2397

1.41

11.51

1.2

1.1

60.50

63.42

u/ml

—

Speech and linguistic disorders, excluding more controls

189

2.81

11.43

1.1

1.2

—

92.64

—

Chronic apical periodontitis

607

2535

1.37

11.23

1.1

36.00

71.85

u/ml

—

Benign neoplasms

524

2070

1.40

11.08

1.2

1.1

68.86

64.41

u/ml

—

Polycystic ovarian syndrome, consortium definition

452

1880

1.43

10.92

1.2

1.1

71.60

61.78

u/ml

—

Personality disorders, excluding more controls

149

825

1.81

10.68

1.1

58.40

62.02

u/ml

—

Other dermatomyositis

17.41

10.57

1.1

—

Certolizumab pegol

4.74

10.54

1.2

—

Chronic diseases of tonsils and adenoids

430

1916

1.42

10.30

1.1

48.20

58.96

u/ml

—

Diseases of the digestive system

220

1374

1.60

9.94

1.3

1.1

—

44.85

—

Selective serotonin reuptake inhibitors

511

1943

1.38

9.78

1.1

61.57

66.41

u/ml

—

Neoplasms

421

1573

1.42

9.77

1.1

73.00

63.47

u/ml

—

Nausea and vomiting

144

795

1.78

9.75

1.2

1.1

—

52.18

—

Spirochaetal infections, other/unspecified

166

976

1.71

9.73

1.1

—

29.69

—

Other skin changes

490

2.01

9.64

1.3

1.1

—

29.87

—

Lyme disease

165

973

1.70

9.58

1.1

—

29.69

—

Diseases of the ear and mastoid process

633

2399

1.33

9.53

1.1

46.20

68.73

u/ml

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

9.16

9.45

1.7

1.2

—

Nonorganic sleeping disorders

125

686

1.83

9.32

1.1

—

59.02

—

Hernia of abdominal wall, postoperative

423

2.07

9.24

1.2

1.1

—

39.78

—

Superficial injury of head

128

714

1.80

9.04

1.1

—

36.03

—

Thrombotic microangiopathy

14.83

8.81

2.4

1.2

—

Disorders of parathyroid gland

113

607

1.85

8.69

1.2

1.1

—

32.37

—

Hypoplasia of dental enamel

7.66

8.54

1.1

1.5

—

Other disorders of the musculoskeletal system and connective tissue

423

2.02

8.53

1.1

—

27.24

—

Dermatographic urticaria

194

2.55

8.48

1.0

1.1

—

33.84

—

Scleritis

5.01

8.42

1.1

—

Genitourinary diseases

276

926

1.50

8.37

1.2

1.1

39.64

76.00

u/ml

—

Crystal arthropathies, rheuma endpoint

7.20

8.29

1.1

1.0

—

Molar incisor enamel hypoplasia, with caries

7.85

8.24

1.1

1.5

—

Dentofacial anomalies [including malocclusion]

389

2274

1.38

8.17

1.2

1.1

73.10

51.41

u/ml

—

Non-allergic asthma (mode), excluding more controls

463

1.93

7.99

1.2

1.1

—

55.40

—

Localized swelling, mass and lump of skin and subcutaneous tissue

155

946

1.64

7.98

1.2

1.1

—

44.91

—

Fall on same level

609

2570

1.30

7.97

1.1

52.80

66.21

u/ml

—

Other crystal arthropathies

6.70

7.93

1.1

1.2

—

Phobic anxiety disorders

421

1.98

7.90

1.1

—

75.60

—

Convulsions, not elsewhere classified

103

556

1.84

7.82

1.1

—

51.43

—

Postviral fatigue syndrome

7.73

7.78

1.1

1.3

—

Other and unspecified immunodeficiencies with predominantly antibody defects

4.64

7.71

1.2

1.1

—

Non-allergic asthma (mode)

470

1.90

7.66

1.2

1.1

—

55.40

—

Deviated nasal septum

145

880

1.65

7.61

1.2

1.1

—

47.67

—

Chronic laryngitis and laryngotracheitis

400

1.99

7.61

1.1

—

41.60

—

Pulmonary eosinophilia, not elsewhere classified

7.32

7.55

1.0

1.1

—

Progressive systemic sclerosis

10.07

7.44

1.1

—

Congenital malformation of biliary tract

17.48

7.42

1.1

1.0

—

Injuries to the knee and lower leg

619

2691

1.28

7.37

1.2

1.1

33.22

73.13

u/ml

—

Intracranial trauma

273

1336

1.44

7.32

1.2

1.1

—

65.14

—

Speech and linguistic disorders

260

2.19

7.31

1.1

1.2

—

39.70

—

Concussion

237

1318

1.47

7.27

1.2

1.1

—

65.14

—

Kela reimbursement Agammaglobulinemia (D80-84)

7.27

7.09

1.2

1.1

—

Personality disorders

149

937

1.60

6.87

1.1

58.40

51.10

u/ml

—

Cholelithiasis

420

2187

1.33

6.85

1.1

66.80

52.42

u/ml

—

Disorders of choroid and retina

371

1959

1.35

6.80

1.2

1.1

40.24

53.00

u/ml

—

Abnormal involuntary movements

362

1.97

6.75

1.2

1.1

—

29.87

—

Other disorders of fluid, electrolyte and acid-base balance

133

777

1.64

6.74

1.1

—

14.53

—

Other abnormalities of plasma proteins

5.60

6.66

1.3

1.1

—

Disturbance of activity and attention

386

1.92

6.54

1.1

1.2

—

79.28

—

Hyperparathyroidism

511

1.79

6.48

1.2

1.1

—

38.60

—

Cholelithiasis, broad definition with cholecystitis

433

2229

1.31

6.47

1.1

66.80

52.05

u/ml

—

Wegener granulomatosis

5.62

6.34

1.8

1.1

—

Hyperkinetic disorders

411

1.87

6.32

1.1

1.2

—

71.24

—

Fracture of lumbar spine and pelvis

565

1.74

6.30

1.2

1.1

—

32.37

—

Viral warts

291

2.04

6.20

1.3

1.1

—

29.87

—

ILD and respiratory illness in diseases classified elsewhere

9.07

6.15

1.3

1.1

—

Ehlers-Danlos syndrome

5.71

6.06

1.2

—

Social phobias

227

2.17

6.05

1.1

—

80.24

—

Lumbosacral root disorders, not elsewhere classified

5.68

6.04

1.0

1.1

—

Primary gonarthrosis, bilateral

228

1374

1.42

6.04

1.1

—

33.93

—

Other specified/unspecified necrotizing vasculopathies

6.15

6.04

1.3

1.1

—

Congenital malformations and deformations of the musculoskeletal system

361

1.91

6.03

1.1

—

55.89

—

Peripheral artery disease

155

802

1.54

6.03

1.1

—

29.60

—

Congenital malformations and deformations of the musculoskeletal system

279

2.05

6.03

1.1

—

40.37

—

Coeliac disease

385

1.88

6.00

1.5

1.1

—

29.87

—

Other obstetric conditions, not elsewhere classified

201

874

1.47

5.94

1.2

1.1

108.71

49.35

u/ml

—

Cerebral palsy and other paralytic syndromes

317

1.97

5.90

1.3

1.1

—

29.87

—

Polymyositis

8.28

5.89

2.3

1.1

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

196

850

1.47

5.83

1.2

1.1

108.71

52.59

u/ml

—

Atherosclerosis, excluding cerebral and coronary sclerosis

143

732

1.55

5.72

1.1

—

29.60

—

Paralytic ileus and intestinal obstruction

109

668

1.64

5.65

1.2

1.1

—

32.90

—

Other/unspecified crystal arthropathies

8.84

5.63

1.2

1.1

—

Other CVD (FINNGEN)

164

2.18

5.53

1.1

—

Pacemaker

119

718

1.59

5.51

1.1

—

36.60

—

Other Crohn's disease

197

2.20

5.50

1.2

1.1

—

27.24

—

Other keratitis

327

1.91

5.43

1.1

—

27.24

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

147

979

1.51

5.36

1.1

—

60.02

—

Disorders of psychological development

337

1.85

5.32

1.1

1.2

—

64.65

—

Acute pharyngitis

479

1.73

5.27

1.2

1.1

—

71.00

—

Sequelae of cerebrovascular disease

136

768

1.53

5.25

1.2

1.1

—

32.33

—

GI-bleeding

127

827

1.54

5.14

1.2

1.1

—

34.80

—

Dermatopolymyositis, unspecified

8.72

5.12

1.6

1.1

—

Injuries to unspecified part of trunk, limb or body region

278

1.95

5.10

1.1

—

33.64

—

Falls/tendency to fall

555

2251

1.24

5.05

1.1

71.17

66.07

u/ml

—

Acne

296

1.90

4.88

1.1

—

70.31

—

Diseases of middle ear and mastoid

285

1766

1.32

4.84

1.1

52.89

73.83

u/ml

—

Abrasion of teeth

171

1200

1.43

4.82

1.2

1.1

—

46.63

—

Disorders of adult personality and behaviour

147

1003

1.47

4.80

1.1

58.40

51.10

u/ml

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

363

1.80

4.80

1.2

1.1

—

29.87

—

Specific personality disorders

125

826

1.52

4.78

1.1

58.40

54.29

u/ml

—

Schizophrenia

488

0.37

4.70

1.2

1.1

—

27.24

—

Seborrhoeic dermatitis

231

2.00

4.69

1.2

1.1

—

29.87

—

Ischaemic heart disease, wide definition

343

1650

1.29

4.67

1.2

1.1

68.40

48.35

u/ml

—

Lesion of lateral popliteal nerve

2.60

4.64

1.4

1.1

—

Haemolytic-uraemic syndrome

10.84

4.62

1.3

—

Senile cataract

272

1260

1.32

4.51

1.1

—

52.67

—

Other retinal disorders

267

1580

1.32

4.46

1.2

1.1

15.44

55.85

u/ml

—

Other diseases of the digestive system

124

831

1.50

4.46

1.2

1.1

—

34.80

—

Scoliosis

224

1.98

4.34

1.1

—

63.20

—

Monoamine oxidase A inhibitors

332

1.79

4.29

1.2

1.1

—

19.84

—

Coronary revascularization (ANGIO or CABG)

361

1748

1.27

4.28

1.2

1.1

68.40

49.48

u/ml

—

153

986

1.43

4.26

1.1

—

32.33

—

Pediculosis, acariasis and other infestations

539

1.60

4.21

1.2

1.1

—

50.15

—

Percutaneous Coronary Intervention

359

1746

1.26

4.16

1.2

1.1

68.40

49.48

u/ml

—

Personal history of other diseases and conditions

401

1.70

4.15

1.1

—

58.03

—

Dental pulpitis, including avohilmo

462

2450

1.23

4.14

1.2

1.1

54.00

67.51

u/ml

—

Otitis media, unspecified

336

1.73

4.12

1.1

1.2

—

57.00

—

6.72

4.04

1.2

1.1

—

Diplopia

361

1.73

4.04

1.1

—

13.84

—

Gastroduodenal ulcer

584

1.56

3.99

1.1

—

27.20

—

Secondary hypertension

155

2.11

3.93

1.0

1.1

—

Other superficial mycoses

2.92

3.91

1.1

1.2

—

Other nonthrombocytopenic purpura

4.90

3.90

1.2

1.1

—

Other and unspecified drugs and medicaments

249

1.86

3.84

1.3

1.1

—

27.24

—

Emergency coronary revascularization (for ACS)

381

1870

1.24

3.82

1.2

1.1

68.40

46.79

u/ml

—

Amputation of foot

3.09

3.82

1.1

—

Acne vulgaris

228

1.90

3.81

1.0

1.1

—

61.44

—

Pyoderma gangrenosum

4.72

3.78

1.4

1.2

—

Major coronary heart disease event

381

1862

1.24

3.73

1.2

1.1

68.40

46.79

u/ml

—

Progressive vascular leukoencephalopathy

2.59

3.72

1.2

1.1

—

ILD medications: pirfenidone

5.74

3.68

1.1

1.0

—

Fissure and fistula of anal and rectal regions

107

728

1.47

3.66

1.1

—

53.28

—

Diabetic nephropathy

345

1.69

3.64

1.1

—

56.84

—

Diabetic nephropathy, excluding more controls

286

1.70

3.61

1.1

1.2

—

50.33

—

Other specified and unspecified disorders of iris and ciliary body

8.09

3.60

1.0

—

Hypoplasia of dental enamel, prenatal

10.80

3.57

1.2

1.0

—

Hypopituitarism

185

1.96

3.52

1.2

—

40.20

—

Noninflammatory disorders of female genital tract

222

850

1.31

3.45

1.1

76.50

73.47

u/ml

—

Recurrent dislocation of patella

107

2.26

3.38

1.0

1.1

—

75.24

—

Ankylosing spondylitis, ICD10

238

1.82

3.38

1.2

1.1

—

27.24

—

Benign neoplasm of mouth and pharynx

298

1.72

3.34

1.1

—

27.24

—

Shigellosis

4.47

3.34

1.4

1.1

—

Polymorphous light eruption

4.47

3.34

1.3

1.0

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

232

1.82

3.33

1.2

1.1

—

55.04

—

Hyperplasia of prostate

110

428

1.46

3.33

1.1

—

73.40

—

Mononeuritis multiplex

9.00

3.30

1.0

—

Meralgia paraesthetica

2.49

3.30

1.3

1.1

—

Hypoplasia of dental enamel, prenatal , including avohilmo

5.54

3.23

1.1

1.2

—

Multifocal fibrosclerosis

5.48

3.22

1.0

1.1

—

Disorders of continuity of bone

295

1.70

3.19

1.0

1.1

—

29.87

—

Cardiac murmurs and other cardiac sounds

263

1.74

3.14

1.1

—

36.03

—

Superficial injury of ankle and foot

389

1.60

3.12

1.1

—

50.15

—

Guillain-Barre syndrome

3.48

3.12

1.1

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

671

0.57

3.11

1.2

1.1

—

37.43

—

Discitis, unspecified

3.71

3.10

1.3

1.2

—

Systemic disorders of connective tissue in diseases classified elsewhere

7.76

3.08

1.2

1.1

—

Nail dystrophy

5.14

3.08

1.3

1.1

—

Intestinal stricture

122

881

1.39

3.08

1.2

1.1

—

34.02

—

Livedoid vasculitis

6.08

3.06

1.1

1.3

—

Malignant neoplasm of digestive organs

883

0.67

3.02

1.0

1.1

—

35.88

—

Acne varioliformis

10.46

3.01

1.0

1.2

—

Portal vein thrombosis

3.60

3.00

1.0

—

Panniculitis, unspecified

4.78

2.93

1.1

—

Other and unspecified acquired haemolytic anaemias

4.17

2.90

1.2

1.1

—

Other and unspecified papulosquamous disorders

6.81

2.88

1.0

1.1

—

Other noninfective disorders of lymphatic vessels and lymph nodes

2.26

2.87

1.2

1.1

—

Dacryoadenitis

4.00

2.80

1.0

—

Microscopic polyangiitis

5.13

2.75

1.1

1.3

—

Other symptoms and signs involving the digestive system and abdomen

532

1.47

2.74

1.2

1.1

—

28.86

—

Hepatomegaly and splenomegaly, not elsewhere classified

3.82

2.69

1.0

—

Infection of intervertebral disc (pyogenic)

3.80

2.68

1.2

1.1

—

Nasal polyp

486

1.49

2.67

1.1

—

47.17

—

Any dementia

673

0.67

2.64

1.1

—

36.60

—

Intrahepatic Cholestasis of Pregnancy (ICP)

251

1.68

2.62

1.2

1.1

—

58.03

—

Overexertion and strenuous or repetitive movements

282

1.64

2.60

1.3

1.1

—

27.24

—

Intracranial injury

246

1893

1.23

2.59

1.2

1.1

—

54.26

—

Cystic fibrosis

7.47

2.58

1.2

1.1

—

Spinal osteochondrosis

4.05

2.58

1.0

1.2

—

Hypersensitivity angiitis

5.60

2.56

1.2

1.0

—

Toxic liver disease

2.90

2.56

1.6

1.1

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

299

1.61

2.56

1.2

1.1

—

55.04

—

Shock, not elsewhere classified

5.52

2.55

1.0

1.1

—

Colonic or urogenital fistula

115

852

1.35

2.55

1.2

1.1

—

30.31

—

Other and unspecified mononeuropathies of lower limb

2.44

2.54

1.2

1.1

—

Dementia, including avohilmo

847

0.71

2.54

1.1

—

36.60

—

Injuries to the neck

100

725

1.38

2.54

1.1

—

50.15

—

Varicose veins

258

1593

1.22

2.53

1.2

1.1

22.60

35.38

u/ml

—

Other immunodeficiencies

3.03

2.50

1.5

1.1

—

Selective deficiency of immunoglobulin G [IgG] subclasses

3.55

2.50

1.1

1.2

—

Cushing syndrome

3.51

2.49

1.0

1.1

—

Gangrene, not elsewhere classified

4.46

2.49

1.0

1.1

—

Other and unspecified primary disorders of muscles

3.89

2.48

1.4

1.2

—

Skin changes due to chronic exposure to nonionizing radiation

130

908

1.32

2.46

1.1

—

32.33

—

Other protozoal intestinal diseases

2.70

2.46

1.1

1.2

—

Scabies

463

1.47

2.45

1.2

1.1

—

50.15

—

Mouth breathing

167

1312

1.27

2.42

1.2

1.1

—

42.59

—

Ectropion of eyelid

2.30

2.41

1.2

1.1

—

Other papulosquamous disorders

3.38

2.40

1.0

1.1

—

Intestinal helminthiases, other/unspecified

6.50

2.40

1.0

—

Alcohol use disorder, Swedish definition

210

1555

1.24

2.39

1.1

—

62.84

—

Other and unspecified localized connective tissue disorders

6.47

2.39

1.0

1.1

—

Dementia

782

0.71

2.39

1.1

—

36.60

—

Lichen planopilaris

6.46

2.39

1.4

1.1

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

305

1.58

2.38

1.2

1.1

—

58.03

—

Iron deficiency anaemia secondary to blood loss (chronic)

426

1.48

2.36

1.2

1.1

—

27.24

—

Artificial joint operation, meniscal resection

388

2154

1.17

2.31

1.2

1.1

28.40

60.36

u/ml

—

Colorectal cancer

574

0.61

2.31

1.1

—

43.17

—

Other and unspecified mood [affective] disorders

207

1.70

2.30

1.1

—

61.44

—

Drug-induced osteoporosis

2.98

2.29

1.0

1.1

—

Other acute viral hepatitis

2.98

2.29

1.1

—

Other and unspecified disorders of orbit

4.73

2.29

1.3

1.1

—

Urticaria due to cold and heat

3.54

2.28

1.1

1.3

—

Other disorders of electrolyte and fluid balance, not elsewhere classified

3.95

2.26

1.0

1.2

—

Defects in the complement system

3.18

2.25

1.7

1.2

—

Diseases of male genital organs

157

618

1.28

2.21

1.2

1.1

—

74.89

—

Persons encountering health services in other circumstances

167

1325

1.26

2.19

1.2

1.1

—

45.07

—

Melanoma in situ of other and unspecified parts of face

3.38

2.19

1.0

1.1

—

Follicular cysts of skin and subcutaneous tissue

525

1.41

2.18

1.2

1.1

—

34.87

—

Actinic keratosis

124

882

1.30

2.17

1.1

—

32.33

—

Intercostal neuropathy

3.75

2.16

1.3

1.2

—

Disorders of parathyroid gland, other and/or unspecified

4.36

2.16

1.7

1.3

—

Haemorrhoids and perianal venous thrombosis

119

910

1.31

2.14

1.2

1.1

—

42.93

—

Carcinoma in situ of skin of lower limb, including hip

2.47

2.11

1.0

1.1

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

546

1.39

2.09

1.2

1.1

—

50.15

—

Selective deficiency of immunoglobulin A [IgA]y

5.12

2.08

1.0

1.2

—

Benign neoplasm: Eye, unspecified

4.11

2.06

1.5

1.3

—

Infective dermatitis

269

1.57

2.05

1.5

1.1

—

27.24

—

Other chondrocalcinosis

2.85

2.01

1.0

1.1

—

Tularaemia

2.85

2.01

1.4

1.2

—

Hypertrophy of breast in women and men

750

1.32

1.97

1.2

1.1

—

46.02

—

Pigmented purpuric dermatosis

3.38

1.97

1.0

1.1

—

Drug-induced adrenocortical insufficiency

2.38

1.96

1.7

1.1

—

Tularaemia

2.38

1.96

1.3

1.1

—

Congenital malformations of heart and great arteries

398

1.44

1.95

1.2

—

36.03

—

Other and unspecified atrophic disorders of skin

4.65

1.95

1.2

—

Common variable immunodeficiency

3.82

1.94

1.2

—

L02BA Anti-estrogens

617

0.66

1.90

1.3

1.1

—

33.70

—

Acute pancreatitis

498

1.39

1.89

1.1

—

27.24

—

Unspecified human immunodeficiency virus [HIV] disease

2.90

1.87

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments at neck level

499

1.39

1.87

1.2

1.1

—

50.15

—

Calculus of kidney and ureter

106

818

1.30

1.87

1.1

—

30.31

—

Anosmia

2.56

1.85

1.1

1.0

—

Other disorders of peripheral nervous system

3.59

1.85

1.2

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

518

1.37

1.83

1.2

1.1

—

36.03

—

Malignant neoplasm of breast, HER2-negative

145

1177

0.80

1.82

1.1

—

44.87

—

Parapsoriasis

2.29

1.81

1.0

1.1

—

Cervical root disorders

3.10

1.81

1.1

—

Other prurigo

2.79

1.80

1.5

1.1

—

Malignant melanoma, including Hilmo

469

1.39

1.80

1.1

—

25.44

—

Contact with and exposure to communicable diseases

1192

0.77

1.79

1.1

—

62.90

—

Other articular cartilage disorders

2.51

1.74

1.0

1.1

—

Chronic inflammatory disorders of orbit

3.99

1.73

1.2

1.1

—

Other or unspecified immunodeficiency

3.95

1.73

1.4

1.2

—

Membranous nephropathy

3.94

1.73

1.6

1.1

—

Tick-borne viral encephalitis

3.92

1.72

1.0

1.3

—

Toxic effect of corrosive substances

3.92

1.72

1.0

1.2

—

Disorders of pituitary gland, other and/or unspecified

3.91

1.72

1.2

—

Polyarteritis nodosa

3.90

1.72

1.4

1.2

—

Endometriosis diagnosis and infertility diagnosis occurring together

391

1.41

1.68

1.1

—

39.84

—

Pemphigus

3.21

1.67

1.0

1.2

—

Disorders of optic nerve and visual pathways

292

1.48

1.67

1.3

1.1

—

27.24

—

Inflammation of lacrimal passages (chronic)

2.60

1.66

1.0

—

Lung transplant status

2.85

1.66

1.1

1.2

—

Sequelae of injuries of upper limb

276

1.49

1.66

1.2

1.1

—

27.24

—

Cicatricial alopecia [scarring hair loss]

2.84

1.66

1.3

1.1

—

Other and unspecified pemphigoid

2.84

1.66

1.0

1.1

—

Urolithiasis

112

888

1.26

1.64

1.1

—

35.65

—

Endometriosis ASRM stages 3,4

110

872

1.26

1.62

1.2

1.1

—

47.24

—

Mature T/NK-cell lymphomas, hilmo

2.52

1.60

1.3

1.1

—

Abscess of lung

2.52

1.60

1.0

1.1

—

Diseases of spleen

2.35

1.59

1.3

1.1

—

Lung transplantation

2.74

1.59

1.1

1.2

—

Otorrhagia

3.05

1.59

1.2

—

Corticotropin deficiency

2.73

1.59

1.1

1.2

—

Malignant neoplasm of colon, including Hilmo

460

0.65

1.58

1.2

1.1

—

36.80

—

Redundant prepuce, phimosis and paraphimosis

410

1.38

1.55

1.1

—

50.20

—

Unspecified transport accident

3.40

1.53

1.4

1.1

—

Benign neoplasm: Endocrine pancreas

3.38

1.53

1.0

1.1

—

Benign neoplasm: Orbit, unspecified

3.38

1.53

1.0

1.1

—

Dementia due to Parkinson's disease

0.00

1.53

0.0

1.1

—

Drug-induced polyneuropathy

2.63

1.52

1.4

1.2

—

Myotonic disorders

2.89

1.51

1.7

1.1

—

Complications predominantly related to the puerperium

129

1054

1.23

1.48

1.2

1.1

—

58.09

—

Fracture of shoulder and upper arm

136

1116

1.22

1.47

1.1

—

42.78

—

Other injuries of upper limb, level unspecified

2.40

1.46

1.0

1.1

—

Infarction of spleen

3.17

1.44

1.4

1.1

—

Migraine, unspecified, drug-induced

2.77

1.44

1.0

1.2

—

Other lesions of median nerve

2.05

1.44

1.0

1.1

—

Other specified/unspecified disorders of bone/cartilage

1.98

1.43

1.2

1.1

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

110

888

1.24

1.42

1.1

—

57.82

—

Other degenerative diseases of the nervous system

542

1.27

1.39

1.2

1.1

—

31.40

—

Defect, injury or illness of neck

2.99

1.36

1.0

1.2

—

D07AA Corticosteroids, weak (group I)

502

1.32

1.36

1.1

1.2

—

59.02

—

Synovial hypertrophy, not elsewhere classified

2.97

1.36

3.2

1.2

—

Horner syndrome

0.00

1.35

0.0

1.1

—

Seborrhoeic keratosis

574

1.29

1.34

1.3

1.1

—

38.60

—

Ventral hernia

707

1.26

1.34

1.1

—

34.87

—

Hyphaema and other vascular disorders of iris and ciliary body

2.16

1.34

1.0

1.1

—

Injuries to the hip and thigh

172

1321

1.18

1.34

1.1

—

42.32

—

Heterophoria

258

1.44

1.31

1.1

—

33.84

—

Other benign neoplasm of uterus: Corpus uteri

2.53

1.31

1.2

1.1

—

Primary amenorrhea

2.53

1.31

1.2

—

Adenocarcinoma and Papillary adenocarcinoma of kidney

2.52

1.31

1.0

1.1

—

Medicines for HER+ breast cancer

119

1364

0.83

1.30

1.1

—

47.75

—

Localized adiposity

2.82

1.29

1.2

—

Explicit fungal Sepsis

2.81

1.29

1.0

1.1

—

Alzheimer’s disease (Atypical or mixed)

171

0.52

1.29

1.1

—

Localized skin eruption due to drugs and medicaments

2.31

1.27

1.1

—

malignant neoplasm of female genital organs

481

0.70

1.27

1.3

1.1

—

31.20

—

Tuberculosis of other organs

2.06

1.27

1.1

—

Carcinoma in situ of skin of scalp and neck

2.06

1.27

1.0

1.1

—

Ovarian dysfunction

260

1.43

1.27

1.3

1.2

—

65.15

—

Puerperal sepsis

483

1.31

1.26

1.1

—

33.70

—

Schizophrenia, schizotypal and delusional disorders

1071

0.80

1.26

1.1

—

46.65

—

2.43

1.25

1.0

1.1

—

Problems related to lifestyle

270

1.41

1.23

1.1

—

46.89

—

Other facial nerve disorders

1.91

1.23

1.0

1.1

—

Benign leiomyoma with endometriosis

547

1.28

1.23

1.1

—

39.84

—

Substance use, excluding alcohol

609

1.27

1.22

1.1

—

45.36

—

Pityriasis lichenoides chronica

2.69

1.22

1.0

1.1

—

conjunctival degenerations and deposits

1.98

1.22

1.7

1.1

—

Tetraplegia

2.66

1.22

1.4

1.2

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

2.18

1.22

1.1

1.2

—

Amoebiasis

2.33

1.19

1.0

1.1

—

Gout due to impairment of renal function

2.33

1.19

1.0

1.1

—

Causalgia

2.12

1.18

2.3

1.1

—

Dementia due to Parkinsons disease, excluding more controls

0.00

1.16

0.0

1.0

—

Other superficial injuries of ankle and foot

2.53

1.15

1.2

—

Superficial injury of shoulder and upper arm

325

1.36

1.15

1.1

—

29.87

—

Malignant neoplasm of breast, ER-positive, including Hilmo

112

1037

0.83

1.15

1.1

—

47.09

—

Dislocation, sprain and strain of joints and ligaments of knee

262

2142

1.13

1.14

1.2

1.1

40.80

67.61

u/ml

—

Malignant neoplasm of breast, HER-positive

109

1021

0.83

1.13

1.1

—

47.09

—

Early syphilis

2.35

1.12

1.3

1.1

—

Chronic myeloproliferative disease

2.35

1.12

1.1

—

Malignant neoplasm of testis

2.35

1.12

1.3

1.0

—

Tonsillectomy and adenotomy

263

1624

1.13

1.11

1.2

1.1

47.04

66.29

u/ml

—

Other and unspecified bullous disorders

2.28

1.11

1.0

1.1

—

Increased muscle tone

2.41

1.09

1.2

—

Recurrent and persistent haematuria

2.40

1.09

1.0

1.1

—

Colitis, primary sclerosing, strict definition

2.21

1.08

1.1

—

Dependence on enabling machines and devices, not elsewhere classified

2.20

1.08

1.1

—

Malignant neoplasm of testis, including Hilmo

2.13

1.05

1.3

1.0

—

Vulvovaginal ulceration/inflammation in other diseases

203

1.43

1.05

1.1

—

55.89

—

Schizophrenia or delusion

1067

0.82

1.04

1.1

—

46.65

—

Ovarian dysfunction, other/unspecified

2.30

1.04

1.4

1.2

—

Acute inflammation of orbit

2.30

1.04

1.6

1.1

—

Neuroendocrine tumor and carcinoma of lung

2.29

1.04

1.0

1.1

—

Benign neoplasm: Nasopharynx

2.29

1.03

1.2

1.1

—

Disorders of porphyrin and bilirubin metabolism

2.08

1.03

1.6

1.1

—

Sequelae of other accidents

2.07

1.03

1.4

1.1

—

Early syphilis

2.01

1.00

1.3

1.1

—

Intentional self-harm by unspecified means

2.01

1.00

1.0

1.2

—

Heartburn

299

1.34

1.00

1.2

1.1

—

28.20

—

Hypersensitivity pneumonitis due to organic dust

2.01

1.00

1.1

—

Leisure time condition

551

0.76

0.99

1.1

—

46.89

—

Postpartum care and examination

365

0.76

0.99

1.2

1.1

—

59.75

—

Hypertrophy of breast

692

1.22

0.98

1.2

1.1

—

46.02

—

Acquired stenosis of external ear canal

2.19

0.98

1.0

1.1

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

0.00

0.98

0.0

1.0

—

Other lack of coordination

1.95

0.97

1.0

1.1

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

503

0.75

0.96

1.0

1.1

—

36.80

—

Family history of malignant neoplasm

410

0.73

0.94

1.0

1.1

—

40.37

—

Amputation of thigh

1.77

0.94

1.0

1.1

—

Late syphilis

1.90

0.94

1.0

1.1

—

Convergent concomitant strabismus

166

1.45

0.94

1.1

—

33.84

—

Complications of labour and delivery

265

1637

0.90

0.93

1.1

82.37

44.45

u/ml

—

Embolic stroke

101

1.59

0.93

1.3

1.1

—

Lesion of radial nerve

1.72

0.92

1.0

1.1

—

Carcinoma in situ of skin of upper limb, including shoulder

1.83

0.92

1.2

1.1

—

Other congenital malformations, not elsewhere classified

2.16

0.92

1.0

1.1

—

Benign neoplasm of ovary

618

1.22

0.90

1.1

—

25.84

—

Injury of eye and orbit

412

1.26

0.88

1.1

—

29.87

—

Hyperkinetic disorders (excl. ADHD)

1.74

0.87

1.4

1.2

—

Acidosis

1.87

0.87

1.0

1.1

—

Unspecified threat to breathing

2.02

0.87

1.0

1.1

—

Burns and corrosions

413

1.26

0.87

1.1

—

29.87

—

Fracture of skull and facial bones

613

1.21

0.85

1.1

—

29.87

—

Other puerperal infections

282

1.32

0.85

1.3

1.1

—

58.03

—

Malignant neoplasm of heart, mediastinum and pleura

1.95

0.84

1.2

1.1

—

Kyphosis

1.95

0.84

1.0

1.2

—

Behavioural disorders

1.76

0.84

1.0

1.2

—

Tic disorders

1.88

0.82

1.0

1.3

—

Tic and related disorders

1.88

0.82

1.0

1.2

—

Injury of muscle and tendon at shoulder and upper arm level

122

1060

1.15

0.81

1.1

—

34.22

—

Fistulae involving female genital tract

1.71

0.81

1.0

1.1

—

Disorder of the sleep-wake schedule

1.71

0.81

2.1

1.2

—

Malignant neoplasm of retroperitoneum and peritoneum

0.00

0.79

0.0

1.1

—

Flatulence and related conditions

0.00

0.79

0.0

1.1

—

Other drug-induced secondary parkinsonism

0.00

0.78

0.0

1.1

—

Open wound of hip and thigh

1.67

0.78

1.0

1.1

—

Unstable angina pectoris

109

743

1.16

0.77

1.1

—

35.17

—

Open bite

174

1.38

0.76

1.1

1.2

—

46.24

—

Other disorders originating in the perinatal period

1.78

0.76

1.2

1.1

—

Tic and related disorders

1.77

0.76

1.0

1.2

—

Xerosis cutis

1.77

0.76

1.0

1.1

—

Injury of nerves and spinal cord at neck level

1.71

0.75

1.1

—

Burns and corrosions of external body surface, specified by site

288

1.29

0.75

1.1

—

33.64

—

Acute myringitis

2.10

0.75

1.2

1.1

—

Unspecified parasitic disease

2.10

0.75

1.6

1.1

—

Carcinoma in situ of vulva

2.10

0.75

1.0

1.1

—

Abnormality of white blood cells, not elsewhere classified

2.10

0.75

1.0

1.1

—

Glaucoma secondary to eye inflammation

2.10

0.75

1.0

1.2

—

Tuberculosis of other organs, strict

1.67

0.74

1.1

—

Abscess of external ear

1.85

0.73

1.3

1.2

—

Car occupant injured in other and unspecified transport accidents

606

1.19

0.73

1.1

—

50.15

—

Testicular hypofunction

1.61

0.72

1.0

1.1

—

Exposure to other and unspecified man-made environmental factors

1.76

0.71

1.0

1.1

—

Anxious personality disorder

1.59

0.71

1.1

1.2

—

Burns and corrosions of multiple and unspecified body regions

1.58

0.71

1.1

—

Other and unspecified mononeuropathies, also in other diseases

1.58

0.71

1.2

1.1

—

Chronic myeloid leukaemia [CML], BCR/ABL-positive

1.94

0.71

1.0

1.1

—

Malignant immunoproliferative diseases

1.94

0.71

1.0

1.1

—

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

1.93

0.71

1.0

1.1

—

Adult respiratory distress syndrome

1.93

0.71

1.2

1.1

—

Other congenital malformations of peripheral vascular system

1.72

0.70

1.0

1.2

—

Paraplegia, diplegia of upper limbs

1.56

0.70

1.1

—

Blood alcohol or alcohol intoxication level

1.56

0.70

1.0

1.1

—

Family history of other specific disorders

1.68

0.68

1.0

1.2

—

Deep endometriosis

311

1.26

0.67

1.1

—

39.84

—

Alcohol use disorder, ICD-based

140

1248

1.12

0.67

1.1

—

59.09

—

Guttate psoriasis

1.64

0.67

1.0

1.1

—

Mesothelioma, including Hilmo

1.79

0.66

1.0

1.1

—

Coarctation of the aorta

1.79

0.66

1.0

1.1

—

Alcohol dependence

724

0.84

0.66

1.1

—

44.74

—

Chronic myeloid leukaemia, including Hilmo

1.73

0.64

1.0

1.1

—

Clubfoot

1.73

0.64

1.0

1.1

—

Atypical mycobacterium lung infection

1.73

0.64

1.2

1.1

—

Mental disorders, not otherwise specified

260

1.27

0.64

1.1

—

33.84

—

Certain conditions originating in the perinatal period

270

1.25

0.63

1.1

1.2

—

80.57

—

Other congenital malformations

288

1.25

0.61

1.0

1.1

—

33.84

—

Other bacterial agents as the cause of diseases classified to other chapters

1.67

0.61

1.0

1.1

—

Congenital musculoskeletal deformities of head, face, spine and chest

1.67

0.61

1.0

1.2

—

Acute and transient psychotic disorders

368

0.79

0.61

1.0

1.1

—

27.24

—

Mastocytosis

0.00

0.60

0.0

1.2

—

Benign neoplasm: Uterine tubes and ligaments

0.00

0.60

0.0

1.2

—

Other congenital malformations of male genital organs

0.00

0.60

0.0

1.0

—

L02BG Aromatase inhibitors

100

1131

0.88

0.60

1.1

—

33.68

—

Mandibular prognathia AND surgery (LeFortI or BSSO)

0.00

0.60

0.0

1.2

—

Congenital malformations of cardiac chambers and connections

0.00

0.60

0.0

1.2

—

Inflammatory disorders of breast

227

1.28

0.60

1.3

1.1

—

55.04

—

Effects of heat and light

0.00

0.59

0.0

1.1

—

Cleft lip and cleft lip and palate

0.00

0.59

0.0

1.2

—

Other congenital malformations of male genital organs

0.00

0.59

0.0

1.0

—

Severe visual impairment, monocular

0.00

0.59

0.0

1.1

—

Erosion and ectropion of cervix uteri

1.53

0.59

1.1

—

Kela-code for behavioural disturbances in mental retardation

0.00

0.58

0.0

1.1

—

Melanoma of uvea

0.00

0.58

0.0

1.1

—

Varus deformity, not elsewhere classified

0.00

0.58

0.0

1.2

—

Malignant neoplasm of breast, HER-negative

700

0.85

0.58

1.1

1.2

—

35.65

—

Isolated proteinuria with specified morphological lesion

1.72

0.58

1.0

1.1

—

Congenital musculoskeletal deformities of head, face, spine and chest

1.72

0.58

1.0

1.2

—

Pervasive developmental disorders excl. Autism + Asperger

1.70

0.57

1.2

1.1

—

Fasciculation

1.68

0.57

1.0

1.1

—

Other and unspecified acne

1.67

0.57

1.2

—

Loose body in joint

1.67

0.56

1.0

1.1

—

Emotional disorders starting during childhood or adolecense, excluding more controls

112

1.40

0.56

1.1

1.3

—

92.64

—

Hypogonadotropic hypogonadism

1.46

0.56

1.1

—

Cellulitis of external ear

1.63

0.55

1.2

1.1

—

Rheumatic fever incl heart disease

1.54

0.55

1.1

—

Open wound of forearm

257

1.25

0.55

1.1

—

33.64

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

150

1357

1.10

0.54

1.1

—

51.95

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

1.58

0.54

1.0

1.2

—

Prolapse and hernia of ovary and fallopian tube

1.46

0.53

1.0

1.1

—

Other and unspecified mononeuropathies of upper limb

1.46

0.53

1.7

1.1

—

Vascular dementia

151

0.70

0.50

1.0

1.1

—

Third [oculomotor] nerve palsy

1.47

0.50

1.0

1.1

—

Embolic stroke with flimmer

1.56

0.49

1.0

1.1

—

Amputation of ankle bones

1.53

0.48

1.1

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

1.49

0.47

1.3

1.1

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

410

1.17

0.47

1.2

1.1

—

27.24

—

Postpartum haemorrhage

100

935

0.90

0.47

1.1

—

45.67

—

Superficial injury of hip and thigh

374

1.18

0.46

1.1

—

29.87

—

Male infertility

0.60

0.45

1.4

1.1

—

Melanocytic naevi of trunk

357

1.18

0.44

1.3

1.1

—

27.24

—

Other complications of labour and delivery, not elsewhere classified

396

1.16

0.44

1.1

—

60.11

—

Benign neoplasm: Oesophagus

1.62

0.43

1.6

1.1

—

Other specified and unspecified disorders of eyelid

1.62

0.43

1.2

1.0

—

Universal erythroderma, KELA reimbursement

1.62

0.43

1.4

1.1

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

1.62

0.43

1.0

1.2

—

Poor fetal growth

471

1.15

0.42

1.2

1.1

—

71.36

—

Arnold-Chiari syndrome

1.57

0.42

1.0

1.2

—

Contusion of toe(s) with damage to nail

1.57

0.42

1.4

1.2

—

Late syphilis

1.57

0.42

1.0

1.1

—

Nontoxic goitre/thyroid nodule

113

1031

1.10

0.42

1.1

—

36.82

—

Malignant neoplasm of gum

0.00

0.41

0.0

1.1

—

Malignant neoplasm of bone and articular cartilage of limbs

0.00

0.41

0.0

1.1

—

Mucinous and mucinous cystic tumor of rectum

0.00

0.41

0.0

1.1

—

Foreign body in genitourinary tract

1.52

0.41

1.0

1.2

—

Benign neoplasm: Connective and other soft tissue of thorax

0.00

0.41

0.0

1.2

—

Malignant neoplasm of nasal cavity and middle ear

0.00

0.41

0.0

1.1

—

Familial erythrocytosis

0.00

0.41

0.0

1.2

—

Other/unspecified mastoiditis and related conditions

0.00

0.41

0.0

1.1

—

Other diseases of appendix

1.52

0.41

1.0

1.1

—

Malignant neoplasm of other and unspecified parts of mouth

0.00

0.41

0.0

1.2

—

Toxoplasmosis

0.00

0.41

0.0

1.3

—

Nosocomial condition (hospital)

0.00

0.41

0.0

1.1

—

Diastasis of muscle

0.00

0.41

0.0

1.3

—

Other bursitis, not elsewhere classified

0.00

0.41

0.0

1.1

—

Malignant neoplasm of base of tongue

0.00

0.41

0.0

1.1

—

Intentional self-harm by jumping from a high place

0.00

0.41

0.0

1.1

—

Benign neoplasm: Brain, infratentorial

0.00

0.41

0.0

1.2

—

Toxic effect of other gases, fumes and vapours

0.00

0.41

0.0

1.2

—

Cleft lip and palate

0.00

0.41

0.0

1.1

—

Bullous keratopathy

0.00

0.41

0.0

1.1

—

Other specified and unspecified disorders of lens

0.00

0.41

0.0

1.1

—

Injury of cranial nerves

0.00

0.41

0.0

1.1

—

Malignant neoplasm of lip

0.00

0.41

0.0

1.0

—

Other deformity of hallux (acquired)

0.00

0.41

0.0

1.2

—

Complications following myocardial infarction

0.00

0.41

0.0

1.2

—

Sequelae of poliomyelitis

0.00

0.41

0.0

1.1

—

Other congenital malformations of nervous system

1.48

0.40

1.0

1.2

—

Pulmonary oedema

1.47

0.40

1.2

1.1

—

Benign neoplasm: Ill-defined sites within the digestive system

0.00

0.40

0.0

1.2

—

Malignant neoplasm of nasal cavity and sinuses

0.00

0.40

0.0

1.1

—

Neuroendocrine tumor and carcinoma of small intestine

1.43

0.39

1.2

1.1

—

Benign neoplasm: Brain, unspecified

0.00

0.39

0.0

1.2

—

Ductal carcinoma of pancreas

0.00

0.39

0.0

1.2

—

Liposarcoma

0.00

0.39

0.0

1.1

—

Other and unspecified spinal muscular atrophies

0.00

0.39

0.0

1.2

—

Unattended death

0.00

0.39

0.0

1.1

—

Other factor of the environment

1.39

0.38

1.2

1.1

—

Carcinoma in situ of skin of trunk

1.33

0.37

1.2

1.1

—

Other intracranial haemorrhages

1.33

0.37

1.1

—

Infections of genitourinary tract in pregnancy

344

0.84

0.37

1.3

1.1

—

74.20

—

Other fall from one level to another

677

1.11

0.36

1.1

—

52.69

—

Arterial embolism and thrombosis of lower extremity artery

1.27

0.36

1.0

1.1

—

Evidence of alcohol involvement determined by blood alcohol level

1.43

0.35

1.0

1.2

—

Injury of urinary and pelvic organs

1.34

0.34

1.0

1.1

—

Pleural plaque without asbestos

1.35

0.32

1.3

1.1

—

Combinations of oral blood glucose lowering drugs

811

0.91

0.31

1.1

—

45.00

—

Other congenital malformations

438

1.12

0.30

1.0

1.1

—

46.89

—

Diabetes mellitus

444

2505

1.04

0.29

1.2

1.1

59.04

62.96

u/ml

—

Diabetes, varying definitions

441

2500

1.03

0.27

1.2

1.1

50.37

63.85

u/ml

—

Unspecified lump in breast

587

1.09

0.26

1.1

—

39.84

—

Cardiac arrest

1.23

0.25

1.1

—

Chalazion

320

1.13

0.25

1.1

—

29.87

—

Diabetes medication

422

2582

0.97

0.25

1.1

50.37

65.04

u/ml

—

Contact with lifting and transmission devices, not elsewhere classified

1.32

0.23

1.0

1.1

—

Maternal care for other known or suspected fetal problems

661

0.94

0.23

1.2

—

60.18

—

Postpartum hemorraghe, all women as controls

100

1045

0.94

0.22

1.1

—

64.48

—

Assault by blunt object

1.25

0.22

1.0

1.2

—

Microtia (small ears)

0.00

0.21

0.0

1.2

—

Cyst of spleen

0.00

0.21

0.0

1.2

—

Medullary carcinoma of thyroid gland, including Hilmo

0.00

0.21

0.0

1.0

—

Tuberous sclerosis 1

0.00

0.21

0.0

1.1

—

Syndactyly

0.00

0.21

0.0

1.0

—

Upper arm

0.00

0.21

0.0

1.1

—

Osteogenesis imperfecta

0.00

0.21

0.0

1.1

—

Other helminthiases

0.00

0.21

0.0

1.2

—

Other and unspecified cicatricial alopecia

0.00

0.21

0.0

1.1

—

Other acantholytic disorders

0.00

0.21

0.0

1.2

—

Immunodeficiency associated with other major defects

0.00

0.21

0.0

1.1

—

Unicornuate uterus

0.00

0.21

0.0

1.1

—

Labyrinthine fistula

0.00

0.21

0.0

1.2

—

Congenital ichthyosis

0.00

0.21

0.0

1.2

—

Exposure to controlled fire, not in building or structure

0.00

0.21

0.0

1.2

—

Cleft lip

0.00

0.21

0.0

1.4

—

Disorders of aromatic amino-acid metabolism

0.00

0.21

0.0

1.1

—

Hypertrophy of bone

0.00

0.21

0.0

1.2

—

Other hyperalimentation

0.00

0.21

0.0

1.4

—

Neuroendocrine tumor and carcinoma of rectum

0.00

0.21

0.0

1.1

—

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

0.00

0.21

0.0

1.1

—

Foreign body granuloma of skin and subcutaneous tissue

0.00

0.21

0.0

1.2

—

Malignant neoplasm of penis

0.00

0.21

0.0

1.1

—

Contact with other hot metals

1.19

0.21

1.2

1.1

—

Open wound of thorax

1.19

0.21

1.0

1.1

—

Alcohol abuse counselling and surveillance

1.19

0.21

1.0

1.1

—

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

0.00

0.21

0.0

1.1

—

Congenital ptosis

0.00

0.21

0.0

1.2

—

Adenocarcinomas of cervix

0.00

0.21

0.0

1.1

—

Brain astrocytoma

0.00

0.21

0.0

1.1

—

Brain astrocytoma, including Hilmo

0.00

0.21

0.0

1.1

—

Exposure to ignition of highly flammable material

0.00

0.21

0.0

1.1

—

Other operation for atrial fibrillation

0.00

0.21

0.0

1.1

—

Malignant neoplasm of uterus, part unspecified, including Hilmo

0.00

0.21

0.0

1.1

—

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

0.00

0.21

0.0

1.0

—

Disorders of other and unspecified cranial nerves

0.00

0.21

0.0

1.2

—

Hydrocephalus in other diseases

0.00

0.21

0.0

1.2

—

Other noninflammatory disorders of cervix uteri

135

1.19

0.21

1.1

—

Other degenerative disorders of eyelid and periocular area

0.00

0.21

0.0

1.1

—

Down's syndrome

0.00

0.21

0.0

1.2

—

Malignant neoplasm of meninges, including Hilmo

0.00

0.21

0.0

1.2

—

Hair colour and hair shaft abnormalities

0.00

0.21

0.0

1.2

—

Nondiabetic hypoglycaemic coma

0.00

0.21

0.0

1.2

—

Cerebral amyloid angiopathy

0.00

0.21

0.0

1.1

—

Female infertility, uterine origin

0.00

0.21

0.0

1.1

—

Carcinoma in situ of endometrium

0.00

0.21

0.0

1.2

—

Chondrosarcoma, including Hilmo

0.00

0.21

0.0

1.0

—

Malignant neoplasm of gallbladder

0.00

0.21

0.0

1.1

—

Blindness or visual impairment, binocular

0.00

0.21

0.0

1.1

—

Frontotemporal dementia

0.00

0.21

0.0

1.0

—

Frontotemporal dementia, wide, incl. Pick's disease

0.00

0.21

0.0

1.0

—

Alzheimer’s disease (undefined), excluding more controls

0.00

0.21

0.0

1.1

—

Adhesive middle ear disease

1.16

0.21

1.0

1.2

—

Mandibular retrognathia

210

1.14

0.21

1.2

1.1

—

33.84

—

Congenital malformations of ear causing impairment of hearing

0.00

0.21

0.0

1.2

—

Osteosarcoma, including Hilmo

0.00

0.21

0.0

1.1

—

Left side

0.00

0.21

0.0

1.3

—

Complications of anaesthesia during labour and delivery

0.00

0.21

0.0

1.3

—

Benign neoplasm: Lower jaw bone

0.00

0.21

0.0

1.1

—

Other proliferative retinopathy

0.00

0.21

0.0

1.2

—

Cleft hard palate NOS

0.00

0.21

0.0

1.2

—

Malignant neoplasm of renal pelvis

0.00

0.21

0.0

1.1

—

Moderate mental retardation

0.00

0.21

0.0

1.2

—

Use of entacapone

0.00

0.21

0.0

1.1

—

Syndactyly

0.00

0.20

0.0

1.1

—

Occupant of special vehicle mainly used on industrial premises injured in transport accident

0.00

0.20

0.0

1.1

—

Chromophobe cell carcinoma of kidney

0.00

0.20

0.0

1.1

—

Right side

0.00

0.20

0.0

1.1

—

Deformity of finger(s)

0.00

0.20

0.0

1.3

—

Sequelae of poliomyelitis

0.00

0.20

0.0

1.1

—

Secondary polycythaemia

1.25

0.20

1.2

1.1

—

Lesion of sciatic nerve

1.22

0.19

1.1

—

Other and unspecified degenerative diseases of nervous system

1.15

0.19

1.2

1.1

—

1.13

0.18

1.3

1.1

—

Other and specified injuries of hip and thigh

1.21

0.18

1.0

1.1

—

Contact with sharp object, undetermined intent

1.17

0.18

1.0

1.2

—

Non-allergic asthma

234

1.11

0.16

1.3

1.1

—

49.40

—

Carcinoma in situ, bladder

1.10

0.15

1.1

—

Malignant neoplasm of oesophagus, including Hilmo

1.13

0.15

1.0

1.1

—

Noise effects on inner ear

1.13

0.15

1.3

1.1

—

Non-small cell lung cancer, squamous, helper endpoint

0.79

0.14

1.0

1.1

—

Acute appendicitis, with complications

604

0.94

0.14

1.2

1.1

—

34.87

—

Crowding of teeth, including avohilmo

277

0.92

0.13

1.2

1.1

—

47.70

—

Postpartum hemorraghe, parous women as controls

100

883

0.96

0.12

1.1

1.2

—

68.77

—

Pedal cyclist injured in noncollision transport accidents

352

0.94

0.10

1.2

1.1

—

27.24

—

Ethmoidectomy

397

1.06

0.10

1.1

—

27.24

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

201

1205

0.98

0.09

1.1

1.2

75.87

54.19

u/ml

—

Hepatocellular carcinoma

1.09

0.09

1.0

1.2

—

Rheumatic valve diseases

1.09

0.09

1.2

1.1

—

Presence of other devices

623

0.96

0.09

1.1

—

22.87

—

Fracture of femur

594

1.04

0.09

1.0

1.1

—

38.60

—

Retinal haemorrhage

1.07

0.08

1.2

1.1

—

Schizophrenia or delusion, excluding more controls

896

0.97

0.07

1.1

1.2

—

69.78

—

Motorcycle rider injured in noncollision transport accidents

0.84

0.07

1.0

1.1

—

Diabetic retinopathy, strict definition

396

0.96

0.07

1.1

—

50.33

—

Non-small cell lung cancer, squamous

0.82

0.07

1.0

1.1

—

FESS (DNB20)

387

0.96

0.07

1.1

—

27.24

—

Other and unspecified nonorganic psychotic disorders

640

0.97

0.06

1.0

1.1

—

45.36

—

Postpartum haemorrhage due to anatomy

367

1.04

0.04

1.2

1.1

—

71.15

—

Other congenital malformations of skin

250

1.04

0.03

1.0

1.1

—

29.87

—

Salpingitis and oophoritis

678

1.02

0.03

1.2

1.1

—

40.42

—

Postpartum haemorrhage due to retained placenta

454

1.01

0.00

1.1

—

71.15

—

Gestational diabetes (for exclusion)

164

1136

1.00

0.00

1.1

1.2

—

66.87

—

Pedal cyclist injured in other and unspecified transport accidents

326

1.01

0.00

1.2

1.1

—

27.24

—

Nontoxic multinodular goitre

593

0.99

0.00

1.1

—

26.20

—

Gestational [pregnancy-induced] hypertension

107

1066

1.00

0.00

1.1

—

44.66

—

Malignant neoplasm of accessory sinuses

0.00

0.0

1.1

—

Other and unspecified postprocedural disorders of eye and adnexa

0.00

0.0

1.0

—

Fusion of the labia

0.00

0.0

1.0

—

Hookworm diseases

0.00

0.0

1.2

—

Malignant neoplasm of other and ill-defined sites

0.00

0.0

1.1

—

Diphtheria

0.00

0.0

1.4

—

Macrocephaly

0.00

0.0

1.0

—

Imperforate hymen

0.00

0.0

1.3

—

Venous complications and haemorrhoids in pregnancy

0.92

0.00

1.0

1.2

—

Absence of one kidney

0.00

0.0

1.1

—

Fetus and newborn affected by other complications of labour and delivery

0.00

0.0

1.1

—

Congenital absence, occlusion, or narrowing of the ear canal

0.00

0.0

1.1

—

Benign neoplasm: Epididymis

0.00

0.0

1.1

—

Fetal blood loss

0.00

0.0

1.2

—

Spina bifida

0.00

0.0

1.0

—

Rickettsioses

0.00

0.0

1.0

—

Marasmic kwashiorkor

0.00

0.0

1.1

—

Erythrasma

0.00

0.0

1.1

—

Abnormal pulmonary venous return

0.00

0.0

1.2

—

Malignant neoplasm of trachea, including Hilmo

0.00

0.0

1.0

—

Injury of blood vessels at forearm level

0.00

0.0

1.2

—

Drug-induced hypopituitarism

0.00

0.0

1.0

—

Effects of other deprivation

0.00

0.0

1.1

—

Exposure to excessive natural heat

0.00

0.0

1.0

—

Lipoprotein deficiency

0.00

0.0

1.3

—

Sequelae of hyperalimentation

0.00

0.0

1.7

—

Other disorders of bone development and growth

0.00

0.0

1.0

—

Abuse of non-dependence-producing substances

0.00

0.0

1.1

—

Benign neoplasm: Aortic body and other paraganglia

0.00

0.0

1.0

—

Noninfective disorders of pinna

0.00

0.0

1.1

—

Benign neoplasm: Central nervous system, other parts/unspecified

0.00

0.0

1.1

—

Post-traumatic hydrocephalus, unspecified

0.00

0.0

1.0

—

ILD medications: acetylcysteine

0.00

0.0

1.0

—

Phantom limb syndrome

0.00

0.0

1.1

—

Mandibular prognathia

1.00

0.00

1.8

1.3

—

Choroidal haemorrhage and rupture

0.00

0.0

1.0

—

Polyp of middle ear

0.00

0.0

1.0

—

Abscess of mediastinum

0.00

0.0

1.0

—

Absence of one kidney

0.00

-0.00

0.0

1.0

—

Congenital myopathies

0.00

-0.00

0.0

1.3

—

Obstetric embolism

0.00

-0.00

0.0

1.1

—

Benign neoplasm: Skin of upper limb, including shoulder

0.96

-0.00

1.2

1.1

—

Profound mental retardation

0.00

-0.00

0.0

1.2

—

Restrictive cardiomyopathy

0.00

-0.00

0.0

1.0

—

Flatback syndrome

0.00

-0.00

0.0

1.2

—

Chondrosarcoma

0.00

-0.00

0.0

1.0

—

Hirsutism, drug-induced

0.00

-0.00

0.0

1.4

—

Intentional self-harm by drowning and submersion

0.00

-0.00

0.0

1.3

—

Acanthosis nigricans

0.00

-0.00

0.0

1.3

—

Lichen striatus

0.00

-0.00

0.0

1.0

—

Sunburn

0.00

-0.00

0.0

1.1

—

Congenital absence, atresia and stenosis of large intestine

0.00

-0.00

0.0

1.0

—

Pseudopolyposis of colon

0.00

-0.00

0.0

1.1

—

Thoracic root disorders

0.00

-0.00

0.0

1.0

—

Motor disorders

0.92

-0.00

1.0

1.2

—

Testicular dysfunction, other/unspecified

0.00

-0.00

0.0

1.1

—

Benign neoplasm: Liver/bile ducts (ICD-9)

0.00

-0.00

0.0

1.0

—

Osteosarcoma

0.00

-0.00

0.0

1.1

—

Tracheo-bronchomalasia

0.00

-0.00

0.0

1.1

—

Complications of anaesthesia during pregnancy

0.00

-0.00

0.0

1.4

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Ciliary body

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of peripheral nerves and autonomic nervous system

0.00

-0.00

0.0

1.1

—

Disorders of vagus nerve

0.00

-0.00

0.0

1.2

—

Sequelae of inflammatory diseases of the central nervous system

0.00

-0.00

0.0

1.3

—

Pregnant state, incidental

0.00

-0.00

0.0

1.5

—

Personal history of certain other diseases

0.91

-0.00

3.0

1.2

—

Other and unspecified water transport accidents

0.00

-0.00

0.0

1.0

—

Defect, injury or illness of lumbar spine

0.00

-0.00

0.0

1.1

—

0.00

-0.00

0.0

1.1

—

Intentional self-harm by smoke, fire and flames

0.00

-0.00

0.0

1.1

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

0.00

-0.00

0.0

1.1

—

Pneumoconiosis due to dust containing silica

0.00

-0.00

0.0

1.0

—

Other haemoglobinopathies

0.00

-0.00

0.0

1.0

—

Occupant of three-wheeled motor vehicle injured in other and unspecified transport accidents

0.00

-0.00

0.0

1.2

—

Drug-induced acute pancreatitis

0.00

-0.00

0.0

1.4

—

Accident to watercraft causing drowning and submersion

0.00

-0.00

0.0

1.2

—

Unspecified multiple injuries

0.00

-0.00

0.0

1.3

—

Sequelae of poisoning by drugs, medicaments and biological substances

0.00

-0.00

0.0

1.0

—

Vascular dementia (sudden onset)

0.00

-0.00

0.0

1.0

—

Traumatic amputation of ankle and foot

0.00

-0.00

0.0

1.3

—

Traumatic cerebral oedema

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Mediastinum

0.00

-0.00

0.0

1.1

—

Other inherited muscular atrophy

0.00

-0.00

0.0

1.3

—

Mental and behavioural disorders due to use of volatile solvents

0.00

-0.00

0.0

1.3

—

Injury of blood vessels at shoulder and upper arm level

0.00

-0.00

0.0

1.2

—

Injury of heart

0.00

-0.00

0.0

1.2

—

Other and unspecified injuries of lower leg

210

1.00

-0.00

1.2

1.1

—

35.04

—

Injury of blood vessels at hip and thigh level

0.00

-0.00

0.0

1.1

—

Dislocations, sprains and strains involving multiple body regions

0.00

-0.00

0.0

1.2

—

Burn and corrosion of respiratory tract

0.00

-0.00

0.0

1.3

—

Sequelae of injuries involving multiple and unspecified body regions

0.00

-0.00

0.0

1.4

—

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

-0.00

0.0

1.3

—

Osteochondrodysplasia with defects of growth of tubular bones and spine

0.00

-0.00

0.0

1.3

—

Chronic constrictive pericarditis

0.00

-0.00

0.0

1.1

—

Epidermolysis bullosa

0.00

-0.00

0.0

1.0

—

Klinefelter syndrome, karyotype 47 XXY

0.00

-0.00

0.0

1.2

—

Hirsprung

0.00

-0.00

0.0

1.0

—

Multiple congenital exostoses

0.00

-0.00

0.0

1.2

—

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

0.00

-0.00

0.0

1.2

—

Congenital malformations of lung

0.00

-0.00

0.0

1.2

—

Fusion of the labia

0.00

-0.00

0.0

1.0

—

Multiple congenital exostoses

0.00

-0.00

0.0

1.2

—

Congenital mitral valve regurgitation

0.00

-0.00

0.0

1.3

—

Craniosynostosis EXCLUDE syndromes

0.00

-0.00

0.0

1.2

—

Congenital ptosis

0.00

-0.00

0.0

1.2

—

Congenital absence, atresia and stenosis of small intestine

0.00

-0.00

0.0

1.0

—

Congenital malformations of lung

0.00

-0.00

0.0

1.2

—

Congenital malformations of nose

0.00

-0.00

0.0

1.3

—

Use of trihexyphenidyl

0.00

-0.00

0.0

1.2

—

Use of bromocriptine

0.00

-0.00

0.0

1.1

—

Congenital malformations of nose

0.00

-0.00

0.0

1.3

—

Other birth injuries

0.00

-0.00

0.0

1.0

—

Intracranial laceration and haemorrhage due to birth injury

0.00

-0.00

0.0

1.2

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

-0.00

0.0

1.0

—

0.00

-0.00

0.0

1.1

—

Birth injury to peripheral nervous system

0.00

-0.00

0.0

1.1

—

Disorders of muscle tone of newborn

0.00

-0.00

0.0

1.2

—

Hereditary lymphedema

0.00

-0.00

0.0

1.0

—

Hereditary lymphedema

0.00

-0.00

0.0

1.0

—

Dysplastic lesion of the vagina of unknown severity

0.00

-0.00

0.0

1.4

—

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

0.00

-0.00

0.0

1.1

—

Ectopic testis

0.00

-0.00

0.0

1.1

—

Traumatic spondylopathy

0.00

-0.00

0.0

1.3

—

Small kidney of unknown cause

0.00

-0.00

0.0

1.2

—

Other hypertrophic osteoarthropathy

0.00

-0.00

0.0

1.0

—

Acquired atrophy of ovary and fallopian tube

0.00

-0.00

0.0

1.0

—

Telogen effluvium

0.00

-0.00

0.0

1.1

—

Radiodermatitis

0.00

-0.00

0.0

1.0

—

Transient acantholytic dermatosis [Grover]

0.00

-0.00

0.0

1.2

—

Perioral dermatitis, drug-induced

0.00

-0.00

0.0

1.1

—

Acné excoriée

0.00

-0.00

0.0

1.0

—

Erythema annulare centrifugum

0.00

-0.00

0.0

1.2

—

Oesophagitis, drug-induced

0.00

-0.00

0.0

1.4

—

Chylothorax

0.00

-0.00

0.0

1.0

—

Moyamoya

0.00

-0.00

0.0

1.2

—

Recurrent cholesteatoma of postmastoidectomy cavity

0.00

-0.00

0.0

1.1

—

Postprocedural disorders of eye and adnexa, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Lens-induced iridocyclitis

0.00

-0.00

0.0

1.1

—

Other and unspecified disorders of sclera

0.00

-0.00

0.0

1.2

—

Other and unspecified disorders of refraction

0.00

-0.00

0.0

1.5

—

conjunctival scars

0.00

-0.00

0.0

1.3

—

Cerebral oedema

0.00

-0.00

0.0

1.3

—

Labyrinthitis

0.00

-0.00

0.0

1.2

—

Physiological and behavioural disorders associated with sexual development and orientation

0.00

-0.00

0.0

1.2

—

Sleep terrors [night terrors]

0.00

-0.00

0.0

1.2

—

Epileptic seizures related to drugs

0.00

-0.00

0.0

1.1

—

Hereditary choroidal dystrophy

0.00

-0.00

0.0

1.0

—

Disorders of tyrosine metabolism

0.00

-0.00

0.0

1.2

—

Diseases of thymus

0.00

-0.00

0.0

1.3

—

Hypothalamic dysfunction, including iatrogenic, not elsewhere classified

0.00

-0.00

0.0

1.1

—

Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism

0.00

-0.00

0.0

1.0

—

Pituitary-dependent Cushing's disease

0.00

-0.00

0.0

1.1

—

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

0.00

-0.00

0.0

1.0

—

Acute necrotizing ulcerative gingivitis

0.00

-0.00

0.0

1.2

—

Pure hyperglyceridaemia

0.93

-0.00

1.2

1.1

—

Monocytic leukaemia

0.00

-0.00

0.0

1.0

—

Carcinoma in situ of oral cavity

0.00

-0.00

0.0

1.3

—

Carcinoma in situ of middle ear and respiratory system

0.00

-0.00

0.0

1.0

—

Cyclic neutropenia

0.00

-0.00

0.0

1.0

—

Cardiomyopathy due to drugs and other external agents

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Larynx

0.96

-0.00

1.0

1.1

—

Combined immunodeficiency, unspecified

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Connective and other soft tissue of abdomen

0.00

-0.00

0.0

1.1

—

Adenocarcinoma of small intestine

0.00

-0.00

0.0

1.2

—

Toxic encephalopathy

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of placenta, including Hilmo

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Cornea

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of pyriform sinus, including Hilmo

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of vagina, including Hilmo

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of vagina

0.00

-0.00

0.0

1.1

—

Bradycardia, unspecified, drug-induced

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of ureter

0.00

-0.00

0.0

1.0

—

Neurofibromatosis, type 2

0.00

-0.00

0.0

1.1

—

Multiple system atrophy (rare forms of Parkinsonism)

0.00

-0.00

0.0

1.3

—

Ependymoma

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of liver and intrahepatic bile ducts

0.98

-0.00

1.0

1.1

—

Pulmonary artery stenosis

0.00

-0.00

0.0

1.2

—

Diphtheria

0.00

-0.00

0.0

1.3

—

Other cestode infections

0.00

-0.00

0.0

1.2

—

Other helminthiases

0.00

-0.00

0.0

1.3

—

Cholera

0.00

-0.00

0.0

1.0

—

Cholera

0.00

-0.00

0.0

1.0

—

Alzheimer’s disease (undefined)

0.00

-0.00

0.0

1.0

—

Rickettsioses

0.00

-0.00

0.0

1.0

—

Ascariasis

0.00

-0.00

0.0

1.2

—

Eccrine sweat disorders

0.00

-0.00

0.0

1.1

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS